Form Bio

AI-driven platform for genetic medicines and genome engineering

Built from URL

Founded 2022

Artificial intelligence and machine learningHealthcareGenetics & GenomicsDeep TechAIBiotechSaaSDrug DiscoveryB2B

Draper AssociatesHealthcare & Biotech

Breyer CapitalAI, AI Health, and Quantum

Aboutbreyer_capital_import

Incubated and spun out of Colossal Biosciences in 2022, Form Bio was developed to empower scientific discovery. The company's mission is to help scientists reach their next breakthroughs faster and with less effort.

ProblemBuilt from URL

Genetic medicine development faces challenges with vector design inefficiencies, CRISPR off-target effects, manufacturing inconsistencies, and slow validation processes that delay bringing therapies to patients.

See something off about this company?